XML 33 R109.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUPPLEMENTARY DATA - QUARTERLY FINANCIAL INFORMATION (UNAUDITED) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Selected Quarterly Financial Information [Abstract]                        
Net sales $ 493,638 $ 404,719 $ 459,233 $ 463,088 $ 402,917 $ 398,805 $ 404,447 $ 280,829 $ 1,820,678 $ 1,486,998 $ 881,591 $ 881,591
Gross Profit 51,529 67,161 82,086 93,363 58,508 52,994 64,334 56,272 294,139 232,108 104,090  
Net Income (Loss) Attributable to Parent (3,501) [1] 19,579 44,056 [2] 35,419 14,461 21,163 25,564 (3,036) [3] 95,553 58,152 (5,926) [4]  
Earnings Per Share [Abstract]                        
Earnings Per Share, Basic $ (0.07) [1] $ 0.46 $ 1.05 [2] $ 0.84 $ 0.34 $ 0.50 $ 0.61 $ (0.07) [3] $ 2.20 [5] $ 1.40 [5] $ (0.17)  
Earnings Per Share, Diluted $ (0.07) [1] $ 0.39 $ 0.84 [2] $ 0.68 $ 0.29 $ 0.42 $ 0.50 $ (0.07) [3] $ 1.83 [5] $ 1.18 [4],[5] $ (0.17)  
Supply agreement termination income                 26,134 0 0  
Noncash Titan Europe Plc gain                 26,700 0 0  
Induced Conversion of Convertible Debt Expense               $ 16,100 $ 0 $ 16,135 $ 0  
[1] Noncash Titan Europe Plc gain of $26.7 million was included in the quarter ended December 31, 2012.
[2] Supply agreement termination income of $26.1 million was included in the quarter ended June 30, 2012.
[3] Noncash convertible debt charge of $16.1 million was included in the quarter ended March 31, 2011.
[4] The effect of stock options/trusts has been excluded as they were anti-dilutive. The weighted-average share amount excluded for stock options/trusts totaled 495,789 shares. The effect of convertible notes has not been included as they were anti-dilutive. The weighted-average share amount excluded for convertible notes totaled 16,764,701 shares.
[5] As a result of changes in outstanding share balances and dilution factors, year-end per share amounts do not agree to the sum of the quarters.